What was the market valuation of the vaccine technologies market in 2024?

The market valuation was $1250.0 Million in 2024. Read More

What is the projected market valuation for the vaccine technologies market by 2035?

The projected valuation for 2035 is $3880.0 Million. Read More

What is the expected CAGR for the vaccine technologies market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period is 10.85%. Read More

Which companies are considered key players in the vaccine technologies market?

Key players include Pfizer, Moderna, AstraZeneca, Johnson & Johnson, Sanofi, GSK, Novavax, Merck, Bharat Biotech, and Sinovac. Read More

What are the main segments of the vaccine technologies market based on type?

The main segments based on type include Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated, and Toxoid. Read More

What was the market size for inactivated vaccines in 2024?

The market size for inactivated vaccines was $400.0 Million in 2024. Read More

What is the projected market size for parenteral vaccines by 2035?

The projected market size for parenteral vaccines by 2035 is $2400.0 Million. Read More

How does the market size for pediatric vaccines compare to adult vaccines in 2024?

In 2024, the market size for pediatric vaccines was $400.0 Million, while adult vaccines reached $850.0 Million. Read More

What distribution channels are utilized in the vaccine technologies market?

Distribution channels include Hospital & Retail Pharmacies, Government Suppliers, and Others. Read More

What was the market size for bacterial disease vaccines in 2024?

The market size for bacterial disease vaccines was $750.0 Million in 2024. Read More

South Korea Vaccine Technologies Market

ID: MRFR/Pharma/50283-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

South Korea Vaccine Technologies Market Research Report: Size, Share, Trend Analysis By Types (Recombinant, Conjugate, Subunit, Inactivated, Live Attenuated, Toxoid), By Route of Administration (Parenteral, Oral), By Disease Indication (Viral Diseases, Bacterial Diseases), By Age Group (Pediatric, Adults) andBy Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Vaccine Technologies Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)10.85%

2024 Market Size$ 1,250 Million

2025 Market Size$ 1,385.62 Million

2035 Market Size$ 3,880 Million

Key Players

Pfizer

Moderna

AstraZeneca

Johnson & Johnson

Sanofi

GSK

Trends

Increased Investment in R&D
Collaboration Between Public and Private Sectors
Focus on Emerging Infectious Diseases

Opportunities

Strategic Partnerships and Collaborations
Technological Advancements in Vaccine Development
Increased Funding for Vaccine Research Initiatives

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Type (USD Million)
  1. 4.1.1 Recombinant/Conjugate/Subunit
  2. 4.1.2 Inactivated
  3. 4.1.3 Live Attenuated
  4. 4.1.4 Toxoid
2. 4.2 Industrial Automation & Equipment, BY Route of Administration (USD Million)
  1. 4.2.1 Parenteral
  2. 4.2.2 Oral
3. 4.3 Industrial Automation & Equipment, BY Disease Indication (USD Million)
  1. 4.3.1 Viral Diseases
  2. 4.3.2 Bacterial Diseases
4. 4.4 Industrial Automation & Equipment, BY Age Group (USD Million)
  1. 4.4.1 Pediatric
  2. 4.4.2 Adults
5. 4.5 Industrial Automation & Equipment, BY Distribution Channel (USD Million)
  1. 4.5.1 Hospital & Retail Pharmacies
  2. 4.5.2 Government Suppliers
  3. 4.5.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Pfizer (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Moderna (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 AstraZeneca (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sanofi (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 GSK (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Novavax (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Bharat Biotech (IN)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
  10. 5.2.10 Sinovac (CN)
    1. 5.2.10.1 Financial Overview
    2. 5.2.10.2 Products Offered
    3. 5.2.10.3 Key Developments
    4. 5.2.10.4 SWOT Analysis
    5. 5.2.10.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY TYPE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY DISEASE INDICATION
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
6. 6.6 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7. 6.7 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
10. 6.10 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
12. 6.12 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISEASE INDICATION, 2024 (% SHARE)
18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISEASE INDICATION, 2024 TO 2035 (USD Million)
19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY AGE GROUP, 2024 (% SHARE)
20. 6.20 INDUSTRIAL AUTOMATION & EQUIPMENT, BY AGE GROUP, 2024 TO 2035 (USD Million)
21. 6.21 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
22. 6.22 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  3. 7.2.3 BY DISEASE INDICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY AGE GROUP, 2025-2035 (USD Million)
  5. 7.2.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Type (USD Million, 2025-2035)

Recombinant/Conjugate/Subunit
Inactivated
Live Attenuated
Toxoid

Industrial Automation & Equipment By Route of Administration (USD Million, 2025-2035)

Parenteral
Oral

Industrial Automation & Equipment By Disease Indication (USD Million, 2025-2035)

Viral Diseases
Bacterial Diseases

Industrial Automation & Equipment By Age Group (USD Million, 2025-2035)

Pediatric
Adults

Industrial Automation & Equipment By Distribution Channel (USD Million, 2025-2035)

Hospital & Retail Pharmacies
Government Suppliers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”